Back
Monopar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75
MNPR
Monopar Therapeutics
Last Price:
30.10
Seasonality Move:
35.55%
7 Day Trial
ALL ACCESS PASS
$
7
This is an offer you won't want to refuse...
Hurry. Don't miss these two trades.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.74 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 16.57 | Buy |
| 200-day SMA: | 6.79 | Buy |
| 8-day EMA: | 25.62 | Buy |
| 20-day EMA: | 22.75 | Buy |
| 50-day EMA: | 17.67 | Buy |
| 200-day EMA: | 9.07 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 62338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.5 - 24.7) | Buy |
| Bollinger Bands (100): | (1.59 - 18.41) | Buy |
Monopar Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 30.68 while MNPR 8-day simple moving average is 24.74, which is a Buy signal.
- The stock price of MNPR is 30.68 while Monopar Therapeutics 20-day SMA is 22.43, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 16.57 while MNPR share price is 30.68, making it a Buy technically.
- MNPR stock price is 30.68 and Monopar Therapeutics 200-day simple moving average is 6.79, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
161.92M
Price in USD:
30.68
Share Volume:
109.38K
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.55
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 30.68 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 30.68 while MNPR 8-day exponential moving average is 25.62, which is a Buy signal.
- The stock price of MNPR is 30.68 while Monopar Therapeutics 20-day EMA is 22.75, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 17.67 while MNPR share price is 30.68, making it a Buy technically.
- MNPR stock price is 30.68 and Monopar Therapeutics 200-day simple moving average is 9.07, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is 2.92, suggesting Monopar Therapeutics is a Buy
- Monopar Therapeutics Relative Strength Index (RSI) is 76.63, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (18.5 - 24.7), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (1.59 - 18.41), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.